Clinical Trials Directory

Trials / Completed

CompletedNCT05311540

Zinc Supplementation In Very Low Birth Weight Infants-A Randomised Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
195 (actual)
Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
Sex
All
Age
7 Days – 9 Days
Healthy volunteers
Not accepted

Summary

* Zinc (Zn) is a structural component of human body and is a crucial element for a wide variety of cascades that take place in almost all organ systems. * Due to many reasons, preterm infants are generally believed to be naturally in a negative Zn balance during the early periods of life. * Regulation of intestinal Zn absorption of preterms is unrelated to infant's Zn status. * There still is a lack of knowledge in the possible relation of Zn deficiency and development of NEC and/or feeding intolerance in preterm infants. * Even if Zn is studied as an adjunct treatment for neonates and young infants with sepsis and found to reduce treatment failure in these high risk population, data in preventing infectious diseases in preterm infants is still lacking.

Detailed description

Background and Objectives: Preterm infants have high zinc (Zn) requirements and are generally believed to be in a negative Zn balance in the early period of life. In this study, we aimed to investigate the effect of high dose Zn supplementation in very low birth weight (VLBW) infants on feeding intolerance and development of mortality and/or morbidities including necrotizing enterocolitis (NEC), late-onset sepsis (LOS). Methods: This is a prospective randomized trial. VLBW preterm infants with gestational age of \<32 weeks were randomly allocated on the seventh day of life to receive extra amount of supplemental zinc along with the enteral feedings or not, besides regular low dose supplementation, from enrollment until discharge. Outcome measures were feeding intolerance, NEC (stage≥2), LOS and mortality.

Conditions

Interventions

TypeNameDescription
DRUGZinc Sulfate

Timeline

Start date
2014-03-14
Primary completion
2015-03-02
Completion
2015-04-20
First posted
2022-04-05
Last updated
2023-02-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05311540. Inclusion in this directory is not an endorsement.